Skip to main content
. 2022 Aug 24;14:955461. doi: 10.3389/fnagi.2022.955461

TABLE 4.

Protein-miRNA interaction validation.

APOC1 APOE HLA-C HLA-DQA1 HLA-DRB1 TOMM40 NECTIN2
miR-199a-5p a, b 0 0 a, b 0 a, b, c a, b
miR-199b-5p a, d 0 0 a, f 0 a, b, c a, b
miR-423-5p 0 0 a, b a, b 0 a, b a, b
miR-3184-5p 0 0 a, b a, b 0 a, b a, b
miR-124-3p a, d 0 0 a, b 0 a, e 0
miR-506-3p a, b 0 0 a, b 0 a, b 0
miR-1321 a, b 0 0 0 a, b, c a, b 0
miR-4731-5p a, b, c 0 0 0 0 a, b a, b
miR-491-5p 0 a, e a, b, c 0 0 a, b 0
miR-663a 0 a, b, c, e 0 0 0 a, b a, b
miR-744-5p 0 a, b 0 0 0 a, b a, b
miR-665 0 a, b, c 0 0 0 a, b a, b
miR-1286 0 a, e 0 0 a, b a, e 0
miR-1908-5p 0 a, b, c, e 0 0 0 a, b a, b
miR-873-5p 0 0 a, c 0 0 a, b a, c

In this table, all protein-miRNA interactions were validated with other databases. In the table, a: Starbase database, b: miRwalk database, c: TargetScan database, d: miRanda database (accessed from starbase database), e: miRmap database, f: microT database. “0” denotes there is no interaction between intended protein and miRNA. Edges that passed the validation process has been bolded.